Trial Details

Recruiting
Basic Information
Clinical ID c2862
Identifier NCT03185000
Trial Title A First in Human Feasibility Study of T Regulatory Cells (TR004) for Inflammatory Bowel Disease Using (ex Vivo) Treg Expansion
Trial URL Visit Original Page
Study Information
Study Results

No results available

Conditions Crohn Disease
Interventions Drug: TR004 (Treg immunotherapy)
Participant Information
Sponsor King's College London
City -
Country/Region United Kingdom
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, ELDER, OLDER_ADULT
Study Design
Study Type Interventional
Phase PHASE1
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -